Peer Review History

Original SubmissionJune 12, 2023
Decision Letter - Ravi Pratap Barnwal, Editor

PONE-D-23-18239Divide, conquer and reconstruct: how to solve the 3D structure of recalcitrant Micro-Exon Gene (MEG) protein from Schistosoma mansoniPLOS ONE

Dear Dr. HOLOGNE,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 28 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ravi Pratap Barnwal, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

3. Thank you for stating the following financial disclosure: 

   "SN : Improvement in Quality of the Internal Grant Scheme at CZU, reg. no. CZ.02.2.69/0.0/0.0/19_073/0016944, financed from the funds of Operational Programme Research, Development and Education, in the framework of ESF Call no. 02_19_073 for Improving the Quality of Internal Grant Schemes at Higher Educational Institutions in priority axis 2 OP"

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript “Divide, conquer and reconstruct: how to solve the 3D structure of recalcitrant Micro-Exon Gene (MEG) protein from Schistosoma mansoni” employed a combination of biophysical techniques, such as circular dichroism and nuclear magnetic resonance (NMR) at natural abundance, along with in silico molecular dynamics simulations. By dividing the protein into shorter fragments, analyzing them individually, and reconstructing the complete structure, the authors successfully tackled the challenge of characterizing this elusive and highly variable protein class. Overall, the manuscript introduces a novel concept for investigating the structural information of MEG proteins, although some minor revision needed.

1. In the abstract, the authors mentioned that all isoforms of MEG 2.1 were analyzed using both biophysical and computational techniques. However, upon reviewing the manuscript, it is apparent that only isoform 1 was analyzed computationally. Therefore, the authors are advised to revise the sentences accordingly to accurately reflect the scope of their computational analysis.

2. The manuscript lacks some important figures, such as the root mean square deviation (RMSD), root mean square fluctuation (RMSF), and radius of gyration (Rg) graphs of the molecular dynamics (MD) trajectory. These figures are crucial for assessing the stability of the protein structure, understanding the extent of residue fluctuations, and evaluating the structural compactness of MEG 2.1. As the manuscript focuses on the structure determination of MEG 2.1 isoforms, it is essential to discuss these results and include the corresponding figures.

3. The authors should carefully review the citation of figures within the text, particularly in the MD results and discussion section. It has been observed that some citations do not match the referenced figures, causing confusion. Therefore, the authors are advised to ensure consistency and accuracy in the citation of figures throughout the manuscript.

4. The article contains grammatical and typographical errors that require scientific editing. It is recommended that the authors carefully review the manuscript to correct these errors and enhance the overall language quality.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.<quillbot-extension-portal></quillbot-extension-portal>

Revision 1

Reviewer #1

1. In the abstract, the authors mentioned that all isoforms of MEG 2.1 were analyzed using both biophysical and computational techniques. However, upon reviewing the manuscript, it is apparent that only isoform 1 was analyzed computationally. Therefore, the authors are advised to revise the sentences accordingly to accurately reflect the scope of their computational analysis.

Following the reviewers’ comment, we modified the sentence in the abstract: “We demonstrated that the combination of biophysical techniques, like circular dichroism and nuclear magnetic resonance at natural abundance, with in silico molecular dynamics simulation for isoform 1 only, was the key to solve the structure of MEG 2.1.”

2. The manuscript lacks some important figures, such as the root mean square deviation (RMSD), root mean square fluctuation (RMSF), and radius of gyration (Rg) graphs of the molecular dynamics (MD) trajectory. These figures are crucial for assessing the stability of the protein structure, understanding the extent of residue fluctuations, and evaluating the structural compactness of MEG 2.1. As the manuscript focuses on the structure determination of MEG 2.1 isoforms, it is essential to discuss these results and include the corresponding figures.

We would like to thank the reviewer to bring to our attention these missing information. Therefore, we added a new figure (Figure 7) in the main text showing the RMSD, RMSF and Rg derived from the MD trajectory. A paragraph was also added in the results part to discuss the data assessing the stability of the protein structure as well as a modified sentence in the discussion part (“Moreover, the 4 μs MD simulation on MEG 2.1 isoform 1 (25-88) shows a transition with the formation of a stable �-helix at the N-terminus and of turns/small helices at the C-terminus (Figures 6, 7)”. A sentence was also added in the Materials and Methods part concerning Rg, RMSD and RMSF calculation.

3. The authors should carefully review the citation of figures within the text, particularly in the MD results and discussion section. It has been observed that some citations do not match the referenced figures, causing confusion. Therefore, the authors are advised to ensure consistency and accuracy in the citation of figures throughout the manuscript.

Following the recommendation of the reviewer, the consistency and accuracy in the citation of the figures were checked carefully before resubmission.

4. The article contains grammatical and typographical errors that require scientific editing. It is recommended that the authors carefully review the manuscript to correct these errors and enhance the overall language quality.

To avoid grammatical and typographical errors, the manuscript was reread carefully, and we tried to do our best to polish our article.

Thus, we believe that we have addressed all reviewers’ concerns.

Attachments
Attachment
Submitted filename: answer-reviewer.docx
Decision Letter - Ravi Pratap Barnwal, Editor

Divide, conquer and reconstruct: how to solve the 3D structure of recalcitrant Micro-Exon Gene (MEG) protein from Schistosoma mansoni

PONE-D-23-18239R1

Dear Dr. HOLOGNE,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ravi Pratap Barnwal, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All the queries have been addressed by the authors. The current form of the manuscript is suitable for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr Prateek Pandya

**********

<quillbot-extension-portal></quillbot-extension-portal>

Formally Accepted
Acceptance Letter - Ravi Pratap Barnwal, Editor

PONE-D-23-18239R1

Divide, conquer and reconstruct: how to solve the 3D structure of recalcitrant Micro-Exon Gene (MEG) protein from Schistosoma mansoni

Dear Dr. Hologne:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ravi Pratap Barnwal

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .